Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ACH — Accendra Health, Inc.
NYSE
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

OCT 30, 2025
REVENUE
$697.3M +2.3%
NET MARGIN
-21.6% +105.9 PTS
EPS
-$1.94 +82.8%
FREE CASH FLOW
-$230.3M -375.2%

No summary has been written for this call yet.